Dr. Hönle AG Statistics

Total Valuation

Dr. Hönle AG has a market cap or net worth of GBP 49.72 million. The enterprise value is 87.75 million.

Market Cap	49.72M
Enterprise Value	87.75M

Important Dates

The last earnings date was Wednesday, January 29, 2025.

Earnings Date	Jan 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	4.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	0.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.83, with an EV/FCF ratio of 30.69.

EV / Earnings	-7.94
EV / Sales	1.07
EV / EBITDA	19.83
EV / EBIT	n/a
EV / FCF	30.69

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.67.

Current Ratio	1.92
Quick Ratio	0.83
Debt / Equity	0.67
Debt / EBITDA	10.04
Debt / FCF	15.50
Interest Coverage	-0.05

Financial Efficiency

Return on equity (ROE) is -14.79% and return on invested capital (ROIC) is -0.04%.

Return on Equity (ROE)	-14.79%
Return on Assets (ROA)	-0.04%
Return on Invested Capital (ROIC)	-0.04%
Return on Capital Employed (ROCE)	-0.08%
Revenue Per Employee	146,754
Profits Per Employee	-19,737
Employee Count	590
Asset Turnover	0.60
Inventory Turnover	1.18

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.26% in the last 52 weeks. The beta is 1.68, so Dr. Hönle AG's price volatility has been higher than the market average.

Beta (5Y)	1.68
52-Week Price Change	-38.26%
50-Day Moving Average	8.59
200-Day Moving Average	14.76
Relative Strength Index (RSI)	54.80
Average Volume (20 Days)	6,128

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Hönle AG had revenue of GBP 82.18 million and -11.05 million in losses. Loss per share was -1.82.

Revenue	82.18M
Gross Profit	49.99M
Operating Income	-84,047
Pretax Income	-10.18M
Net Income	-11.05M
EBITDA	3.26M
EBIT	-84,047
Loss Per Share	-1.82

Full Income Statement

Balance Sheet

The company has 6.25 million in cash and 44.30 million in debt, giving a net cash position of -38.06 million.

Cash & Cash Equivalents	6.25M
Total Debt	44.30M
Net Cash	-38.06M
Net Cash Per Share	n/a
Equity (Book Value)	66.31M
Book Value Per Share	10.90
Working Capital	24.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.60 million and capital expenditures -1.74 million, giving a free cash flow of 2.86 million.

Operating Cash Flow	4.60M
Capital Expenditures	-1.74M
Free Cash Flow	2.86M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.83%, with operating and profit margins of -0.10% and -13.45%.

Gross Margin	60.83%
Operating Margin	-0.10%
Pretax Margin	-12.39%
Profit Margin	-13.45%
EBITDA Margin	3.97%
EBIT Margin	-0.10%
FCF Margin	3.48%

Dividends & Yields

Dr. Hönle AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-22.23%
FCF Yield	5.75%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Hönle AG has an Altman Z-Score of 1.95. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.95
Piotroski F-Score	n/a